The memory chip industry will face more difficult times the rest of the year, according to Evercore ISI, which lowered its earnings estimates for Micron …
Check Also
Rebuttal To A Bearish Article About Amarin
Confusion remains about Amarin’s blockbuster trial results for its cardiovascular protection drug, Vascepa. A recent …